Catalyst Pharmaceuticals, Inc. (CPRX) — SC 13G/A Filings
All SC 13G/A filings from Catalyst Pharmaceuticals, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Oct 18, 2024
- SC 13G/A Filing — Oct 17, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Deerfield Mgmt Exits Catalyst Pharma (CPRX) Position
— Feb 12, 2024 Risk: medium
Deerfield Mgmt, L.P. and its affiliates, including Deerfield Management Company, L.P. and Deerfield Partners, L.P., have filed an amended SC 13G/A for Catalyst -
State Street Amends Passive Stake in Catalyst Pharma
— Jan 25, 2024
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Catalyst Pharmaceuticals Inc. commo -
BlackRock Amends Catalyst Pharma Stake (SC 13G/A)
— Jan 22, 2024
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in their ownership of Catalyst Pharmaceuticals Inc. common stock as of Decembe
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX